|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 06742962.1 (espacenet) (Federated) (European Patent Register), 20060517 | | Patent/reg. no. and date | DK/EP 1888640, 20120314 | | Publication date | 20080220 | | Priority no. and date | US 682332 P, 20050518 | | EP pub. no. and date |
EP 1888640 20080220 | | Effective date | | | Applicant/owner | Ablynx N.V., Technologiepark 21
9052 Ghent-Zwijnaarde, BE | | Applicant ref. no. | ABLYNX 1888640 | | Inventor | BEIRNAERT, Els, Markettestraat 20a
B-9881 Bellem, BE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61P 29/00 (2006.01) , C07K 16/18 (2006.01) , C07K 16/24 (2006.01) | | Title | Forbedrede nanobodies mod tumornekrosefaktor-alfa | | Int. application no. | EP2006004678 | | Int. publication no. | WO2006122786 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
